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Materials and Methods

Instrumentation
A Model 110 A pump (Altex Scientific Inc., Berkeley, CA 97410) was used to deliver the solvent through a 250 X 4.6 mm (i.d.) column of Lichrosorb RP 18 of 10-itm average particle size (E. Merck, Cincinnati, OH 45212) at a flow rate of 1.5 mL/min. The samples were introduced through a 20-tL loop injector, Model 7120 (Rheodyne Inc.,Berkeley, CA 94710). 
Results and Discussion
Recorder response isplottedin Figure 1 as a function of the oxidation potential of HVA with a glassy carbon electrode. We found that two different glassy carbon electrode cells showed different maxima for their oxidation potential; therefore, the voltage at which the response is maximized should be determined for each cell. Representative chromatograms of a normal specimen, an above-normal specimen, and a standard are illustrated in Figure 2 . The retention time for HVA is 10 mm with the routine mobile phase of methanol/phosphate buffer. The method is linear between 1 and 100 mg/L. The average analytical recovery of HVA added (20 mg/L) to five different urine pools was 98%. The reproducibility of the method is summarized in Table 1 .
Results from direct urine injection were compared with those from solvent extraction with dichloromethane. Solvent extraction was quite selective and yielded a cleaner chromatogram-most of the extraneous peaks eluting close to HVA were absent. However, the patients' values for HVA were similar by the two methods ( method, especially the last group, who had been treated with L-dopa.
The effects of direct urine injection on column performance have also been described (6). Phe method we propose, compared with other methods for HVA assay, is quite simple, specific, free from interferences, and suitable for automation.
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Blood Thyroxine Concentration Is Lower in Low-Birth-Weight Infants Jean H. Dussault, Jean Morissette, and Claude Laberge
From our data bank, we analyzed results for thyroxine concentration in blood samples spotted on filter paper from different age groups (one to nine days postpartum) of our low-birth-weight and normal population. It was significantly lower in the low-birth-weight infants in almost all the age groups, and in both groups it significantly declined after postnatal day 5. The influence of weight is more important in the low-birth-weight population, but does not completely explain the smaller values. The results indicate that blood samples used in screening for congenital hypothyroidism in the neonate should be taken on postnatal days 3 to 5, and if a recall specimen is collected on days 5 to 9, one should expect the thyroxine concentration in the second specimen to be lower than in the first. 
Methods
We pooled data collected during three years of such screening of T4 in neonates. Our previous study (4) showed that the mean and variance varied significantly between assays; thus the results were standardized so that the specimen population had the same distribution from day to day. From our data and the form accompanying the specimen (5) we took the following three variables: T4, weight, and age of child. An analysis of covariance was made, in which T4 was related to birth weight, and groups were formed from infants having the same age.We separated infantsthat weighed less than 2.5 kg at birth from those that weighed more and classified the former as infants with LBW.
Results
As shown in Table I and Figure 1 , between two and nine days after birth, LBW newborns show T4 concentrations that clearly are statistically (p <0.0001) lower than those for infants with normal birth weights. Changes in these concentrations in the two groups parallel one another, attaining their lowest point at nine days of age (1.4 ng per 40 uL of eluted blood, compared with 1.6 ng for the normal infants). The correlation between birth weight and T4 concentration in the normal-weight infantsisgreater in the first two days of life; thereafter it stabilizes at around r 0.1. In the LBW infants the correlation is greatest at about the sixth day of postnatal life and is more significant: the regression coefficient in the LBW group was almost fivefold that of normal weight infants
